Regeneron has faced a lower stock price and patent wrangling. But the stock could be ready to rise again.
- TheStreet.com•2 days ago
Look at what they are buying.
- Motley Fool•3 days ago
Why you should keep your eyes on Amgen, Jazz, Lexicon, Regeneron, and Synergy in Q1.
REGN : Summary for Regeneron Pharmaceuticals, Inc. - Yahoo Finance
Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||358.00 x 500|
|Ask||364.80 x 100|
|Day's Range||362.13 - 369.69|
|52 Week Range||325.35 - 482.27|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||52.90|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|